Skip to content

The translational and applied research of key technology on patients with coronary artery disease using TCM on prevention and treatment: a randomized controlled clinical trial on patients with coronary artery disease after intervention therapy

The translational and applied research of key technology on patients with coronary artery disease using TCM on prevention and treatment: a randomized controlled clinical trial on patients with coronary artery disease after intervention therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-14005578
Enrollment
Unknown
Registered
2014-11-28
Start date
2012-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Interventions

Treatment Group :Chinese Patent Medicine combined with conventional Western medicine

Sponsors

Xiyuan Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Patients with acute coronary syndrome after successful coronary artery interventional treatment for the first time; (2) sign consent form voluntary

Exclusion criteria

Exclusion criteria: (1) patients with left main coronary artery; (2) The TCM syndrome were out of heart blood stasis or qi deficiency and blood stasis or the phlegm and blood stasis; (3) The number of platelet less than 7*10^9/L or the patients with bleeding tendency; (4) Patients with poor adherence; (5) Women during pregnancy and lactation; (6) Affect data collecting due to spirit or language; (7) Complicated with severe immune system or infectious disease; (8) Combined with severe gastrointestinal disease, such as a history of gastrointestinal bleeding or severe gastrointestinal ulcers.

Design outcomes

Primary

MeasureTime frame
Endpoint event;

Secondary

MeasureTime frame
The integral of blood stasis syndrome;The score of primary clinical symptom;electrocardiogram;ultrasonic cardiogram;Seattle Angina Questionnaire;physical and chemical indicators;

Countries

China

Contacts

Public ContactShi Dazhuo
shidazhuo@126.com+86 13511072856

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026